Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium Hypochlorite Rinse in Atopic Dermatitis
NCT02241174Phase 1Withdrawn
- Sponsor
- Makati Medical Center
- Start
- Jul 2014
- Primary completion
- Dec 2014
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in atopic dermatitis (AD) comparing Sodium Hypochlorite with Placebo (2 arms). Primary endpoints: Culture and sensitivity findings at 12 weeks, Eczema Area and Severity Index at 12 weeks and 1 more. Planned start Jul 2014; status: withdrawn.
02
Drugs
sodium hypochlorite
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT02241174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02241174.